Given that Raf, Raf and KSR1 activities were not directly affected by the loss TPL2 kinase activity in IKKɛ-deficient tumor cells, there may be other mechanisms for the inhibition of canonical Ras/RAF/MAPK activation. This evidence concerns the gene KSR1 and neoplasm.